Ustekinumab Drug Level ELISA (IDKmonitor®)

Product code: K9660 (96 wells)

Determination of free therapeutic ustekinumab

Ustekinumab is a recombinant protein used to treat inflammatory bowel disease (IBD). The IDKmonitor Ustekinumab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free ustekinumab in plasma or serum samples. Not all patients respond equally to ustekinumab, and this test helps to stratify patients according to whether they are likely to benefit from treatment or not, allowing clinicians to evaluate the drug efficacy and investigate primary non-response, loss of response and non-remission.

Please contact us for your nearest test reference laboratory.

Key Advantages

Highly specific quantification of ustekinumab, with no cross reaction with compounds of a similar structure
Total incubation time 130 minutes
Saves costs by predicting efficacy of ustekinumab treatment and stratifying patients accordingly
Applicable to both gastroenterology and rheumatology
Reportable range 0.29-60 ug/ml
Automatable on ELISA automates (e.g. Dynex DS2)

Specifications

ELISA

40 tests

Storage: 2-8 °C

Blood sample


Related Products

    Ustekinumab Free Anti-drug Antibody ELISA (IDKmonitor®)

    Ustekinumab is a fully humanised IgG1 therapeutic monoclonal antibody used for the treatment of Crohn’s disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis. This assay enables the reliable determination of free, unbound anti-drug antibodies.

    Ustekinumab Total Anti-drug Antibody ELISA (IDKmonitor®)

    Ustekinumab is a fully humanised IgG1 therapeutic monoclonal antibody used for the treatment of Crohn’s disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis. This drug-tolerant assay enables the reliable determination of anti-drug antibodies even in the presence of ustekinumab.